Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predictive value of primate models for AIDS.

Nancy L Haigwood1

  • 1Viral Vaccines Program, Seattle Biomedical Research Institute, Seattle, WA 98109, USA. Nancy.Haigwood@sbri.org

AIDS Reviews
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Planning for the future of the American Society for Microbiology's Health Unit by the Council on Microbial Sciences.

mSphere·2026
Same author

Monoclonal Antibodies for Pediatric Viral Disease Prevention and Treatment.

Pediatrics·2025
Same author

Immune perturbation following SHIV infection is greater in newborn macaques than in infants.

JCI insight·2024
Same author

Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates.

Science (New York, N.Y.)·2024
Same author

Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology.

Nature communications·2023
Same author

Evidence for the Role of a Second Fc-Binding Receptor in Placental IgG Transfer in Nonhuman Primates.

mBio·2023

Nonhuman primate models for HIV infection show promise in predicting human responses to therapies and vaccines. Despite challenges in validation, these models offer valuable insights for accelerating the development of effective HIV treatments and preventative strategies.

Area of Science:

  • Virology
  • Immunology
  • Preclinical Research

Background:

  • Human Immunodeficiency Virus (HIV)-1 primarily infects humans and chimpanzees, limiting preclinical research models.
  • Nonhuman primate lentivirus models mimic HIV infection, disease progression, and immune responses, aiding research.
  • Validation of animal models for HIV is challenging, especially for vaccine efficacy, due to the lack of successful human trials.

Purpose of the Study:

  • To review data from nonhuman primate models of lentivirus infection and pathogenesis.
  • To critically evaluate the predictive accuracy of these models for human outcomes.
  • To assess the contributions of these models to understanding HIV pathogenesis, therapeutics, and vaccine development.

Main Methods:

  • Review of existing literature on nonhuman primate lentivirus models.

Related Experiment Videos

  • Comparative analysis of data from primate models versus human clinical data.
  • Evaluation of model congruence with clinical findings for drug action and immune responses.

    • Main Results:

    • Nonhuman primate models have recapitulated key aspects of HIV infection and pathogenesis.
    • Data from these models on drug efficacy and immune responses to vaccines align with clinical observations.
    • Despite validation challenges, primate models have provided valuable information for therapeutic and vaccine development.

    Conclusions:

    • Nonhuman primate models are valuable adjunctive systems for prioritizing HIV therapeutic and vaccine strategies.
    • These models can significantly enhance and accelerate the evaluation of novel concepts for effective HIV interventions.
    • Continued research in nonhuman primate models is crucial for addressing remaining gaps in HIV vaccine and therapy development.